BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3543678)

  • 1. Antibiotic therapy in cancer patients with fever and neutropenia.
    N Engl J Med; 1987 Feb; 316(7):410-2. PubMed ID: 3543678
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
    Pizzo PA; Hathorn JW; Hiemenz J; Browne M; Commers J; Cotton D; Gress J; Longo D; Marshall D; McKnight J
    N Engl J Med; 1986 Aug; 315(9):552-8. PubMed ID: 3526155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
    Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime as a single agent in the management of children with fever and neutropenia.
    Morgan G; Duerden BI; Lilleyman JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():347-51. PubMed ID: 6352641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
    Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
    Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infections in neutropenic children with neoplasms. Case series contribution].
    Giacchino M; Artino RM; Miniero R; Grazia G; Vivalda M; Dotti G; Mattirolo F; Madon E
    Minerva Pediatr; 1988 Jun; 40(6):339-44. PubMed ID: 3054471
    [No Abstract]   [Full Text] [Related]  

  • 8. Monotherapy with pefloxacin in neutropenic febrile patients.
    Daniels-Bosman MS; Beun GD; Debrus-Palmans LL; Blijham GH
    Chemioterapia; 1987 Jun; 6(2 Suppl):410. PubMed ID: 3509459
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M; Clavell LA
    P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime as monotherapy for fever and neutropenia: experience in a community hospital.
    Bizette GA; Brooks BJ; Alvarez S
    J La State Med Soc; 1994 Oct; 146(10):448-52. PubMed ID: 7798779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
    de Pauw B; Williams K; de Neeff J; Bothof T; de Witte T; Holdrinet R; Haanen C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):824-8. PubMed ID: 3909956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    Verhagen C; De Pauw BE; Williams KJ; Du Bois W
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):178-82. PubMed ID: 3134208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
    d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
    J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.